help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on January 25, 2007, doi:10.1164/rccm.200607-1011OC

Am. J. Respir. Crit. Care Med., Volume 175, Number 8, April 2007, 816-821

A more recent version of this article appeared on April 15, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200607-1011OCv1
175/8/816    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henke, M. O
Right arrow Articles by Rubin, B. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henke, M. O
Right arrow Articles by Rubin, B. K

Submitted on July 24, 2006
Accepted on January 25, 2007

MUC5AC and MUC5B Mucins Increase in Cystic Fibrosis Airway Secretions During Pulmonary Exacerbation

Markus O Henke1*, Gerrit John1, Michele Germann1, Hermann Lindemann2, and Bruce K Rubin3

1 Department of Pulmonary Medicine, Philipps-University Marburg, Marburg, Germany, 2 Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany, 3 Department of Pediatrics, Wake Forest University Health Sciences, Winston-Salem, NC, USA

* To whom correspondence should be addressed. E-mail: markus.henke{at}staff.uni-marburg.de.

Rationale: Cystic fibrosis (CF) is thought to be associated with mucus hypersecretion and thus the principal airway gel-forming mucins, MUC5AC and MUC5B, are also expected to be increased relative to non-CF secretions. However we have shown that these mucins are decreased during stable CF disease. Objectives: In this study we determine if these mucins increase during a pulmonary exacerbation of CF. Methods: Expectorated sputum was collected from 11 adults with CF during stable disease and then during a pulmonary exacerbation and from 12 healthy controls. MUC5AC and MUC5B proteins were measured by western blot. DNA content was measured using microfluorimetry. Results: MUC5AC protein increased by 908% and MUC5B by 59% (p < 0.05 for both) during an exacerbation compared with periods of stable disease. During stable disease, the v/v quantity of MUC5AC protein was 89% less than normal mucus and the mucin-associated sugars, measured using a lectin binding assay were 46% less compared to normal mucus. The concentration of DNA in CF sputum did not increase during an exacerbation. Conclusions: During a CF exacerbation, concentration of secreted mucin increased to the amount found in mucus from normal subjects suggesting that the capacity to secrete mucin in response to an infection or inflammatory stimulus is preserved in CF airways. This might help to protect the airway from injury.


Key words: Respiratory; Mucus; Hypersecretion; Mucin; DNA




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in Cystic Fibrosis 2007
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1058 - 1061.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. J. Broughton-Head, J. Shur, M. P. Carroll, J. R. Smith, and J. K. Shute
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1240 - L1249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  2009 ATS Conference Fees